about
Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia culturesA growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse casesIncreased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma.Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment.Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms.Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abusePreferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.HIV neuropathogenesis: a tight rope walk of innate immunity.Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitisAssociation of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis.Human immunodeficiency virus type 1 infection of human brain-derived progenitor cellsHuman retinal microglia express candidate receptors for HIV-1 infection.HIV-1 Tat-mediated neurotoxicity in retinal cells.Dorsal root ganglia damage in SIV-infected rhesus macaques: an animal model of HIV-induced sensory neuropathy.HIV-1 infection and AIDS: consequences for the central nervous system.Opiate drug use and the pathophysiology of neuroAIDS.Molecular targets of opiate drug abuse in neuroAIDS.NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.Nonhuman primate models of NeuroAIDSNeuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS.Platelet-derived growth factor protects neurons against gp120-mediated toxicityMechanisms of platelet-derived growth factor-mediated neuroprotection--implications in HIV dementia.Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium.Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice.Molecular pathology of neuro-AIDS (CNS-HIV).Genotypical diversity of HIV clades and central nervous system impairment.The effects of opioids on the lung.Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons.CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis
P2860
Q28212110-432BB787-87CF-4870-8417-FADB4D30F12EQ28477511-70A7D903-453F-4FFB-8FA1-52845744C86CQ33792327-C6FF93E0-57D1-443D-8660-37FD799887FDQ33842214-DAC48282-A9CB-4A78-B133-0EE702FC1203Q34164664-2B428E48-C691-4815-BA21-E2F6FD74AB28Q34416948-BA25DDF1-D05C-4024-8580-A0E593095573Q34450960-C5F2204A-3C22-471B-B5A6-9F9E5E0FE802Q34797566-10F42B98-72C7-4D64-B9E6-8291CCEC3B65Q35007339-4AB034ED-2CBB-4A24-8E50-87251DA3A54FQ35009465-B08C1AE8-7CB2-49DB-B70E-DBB937D751ECQ35009483-BD6F607C-B55A-4BB1-AF20-BE33756AEE98Q35063626-2D53DDF3-6074-41EC-A29D-ECE6C93E6BFCQ35098067-33BC5B69-E4FC-43DC-8E5A-D09C527EF620Q35103153-A62BFE66-52D0-4803-B8FE-7B9CC2D11BA7Q35123435-9CEF68DE-117F-47C9-AF5C-63ACF5F0B088Q35593291-FE2EC171-2AE1-4456-B57E-33B8598E2257Q35875211-858C6AFE-3DF2-494A-AA98-D4995D94ECD5Q35952086-95ABA40F-E994-4C41-BEF7-D6C090EF3FC7Q36098879-9406A4EC-0EBF-4BE7-A400-4208E8F83749Q36201412-95BBF486-EE95-49C1-B689-C5D77942C875Q36302053-08FEE983-ED36-4471-88DA-389435EA934EQ37089861-D93460F4-97F4-4DC9-A36E-2D5F52C51469Q37133136-CF62BC41-3025-4812-9B05-61A511E0EDA9Q37264017-C2850FB0-19FC-4A6A-8B35-D58D4E77D401Q37264028-F1EE31BB-852F-42F9-BF1B-4065F525E636Q37275841-11836A11-4C97-4C21-849A-5D8997956B9FQ37276062-4B7DB0AE-9BAC-4313-9F21-9A62487ED01BQ37300421-D820B279-2F35-4F4C-A8C4-DA9BD52A5E79Q37366558-CADF82B9-E3F5-47C4-894A-803295B9A3CAQ37409631-672BD86B-30CD-4683-BCD8-3A6417F4909FQ37462244-82A43E87-F4EB-4C38-BAE0-92A0196B8E27Q37980665-AEEA12F0-8B86-4879-A02A-4085A5C0094DQ38103476-8FAA6CE0-AD24-4575-906D-552B78AA3D8BQ39921141-BB70F15B-DFEB-47BF-A3AA-6606B7BD9815Q40455681-52E6E2BC-4D26-4096-B1B0-9523EA77709AQ40618194-4D6FD10F-7982-4839-8C11-D7828B2C06D9Q41841039-237B5493-06DC-43F3-8303-AF4F6CD088E3Q41869742-BE1F0968-BDE5-4D1A-8F50-56BF7CDEB9FFQ42135420-793914DD-60A0-40BF-AEBB-1A60393E295BQ42743771-692719A5-38C2-418B-83CF-03C3ED17A3A8
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pathobiology of human immunodeficiency virus dementia.
@ast
Pathobiology of human immunodeficiency virus dementia.
@en
type
label
Pathobiology of human immunodeficiency virus dementia.
@ast
Pathobiology of human immunodeficiency virus dementia.
@en
prefLabel
Pathobiology of human immunodeficiency virus dementia.
@ast
Pathobiology of human immunodeficiency virus dementia.
@en
P356
P1476
Pathobiology of human immunodeficiency virus dementia.
@en
P2093
P304
P356
10.1055/S-2008-1040830
P577
1999-01-01T00:00:00Z